Follow the Hansa Biopharma AB share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Hansa Biopharma AB has recorded 13 public disclosures. Market capitalisation: €3.9bn. The latest transaction was filed on 18 August 2026 (Sale). Among the most active insiders: Michael Bologna. Every trade is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€2m
6 ops.
Buy Volume
€3m
7 ops.
Sell Volume
39Σ signal
Buys €2m€3m Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
300 shares@ SEK 185.70100.0% of flowAktieISINISIN SE0002148817FI:A001P621-2
13 of 13 declarations
About Hansa Biopharma AB
Hansa Biopharma AB is a biopharmaceutical company focused on developing treatments for patients with unmet medical needs. It is listed on the Stockholm Stock Exchange.